Patents by Inventor Janet C. Cheetham

Janet C. Cheetham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thrombopoietic compounds
    Patent number: 9534032
    Abstract: The invention relates to the field of compounds, especially peptides or polypeptides, that have thrombopoietic activity. The peptides and polypeptides of the invention may be used to increase platelets or platelet precursors (e.g., megakaryocytes) in a mammal.
    Type: Grant
    Filed: April 30, 2014
    Date of Patent: January 3, 2017
    Assignee: AMGEN INC.
    Inventors: Chuan-Fa Liu, Ulrich Feige, Janet C. Cheetham
  • Thrombopoietic compounds
    Patent number: 9145450
    Abstract: The invention relates to the field of compounds, especially peptides or polypeptides, that have thrombopoietic activity. The peptides and polypeptides of the invention may be used to increase platelets or platelet precursors (e.g., megakaryocytes) in a mammal.
    Type: Grant
    Filed: January 19, 2006
    Date of Patent: September 29, 2015
    Assignee: AMGEN INC.
    Inventors: Chuan-Fa Liu, Ulrich Feige, Janet C. Cheetham
  • THROMBOPOIETIC COMPOUNDS
    Publication number: 20150024431
    Abstract: The invention relates to the field of compounds, especially peptides or polypeptides, that have thrombopoietic activity. The peptides and polypeptides of the invention may be used to increase platelets or platelet precursors (e.g., megakaryocytes) in a mammal.
    Type: Application
    Filed: April 30, 2014
    Publication date: January 22, 2015
    Applicant: AMGEN INC.
    Inventors: Chuan-Fa Liu, Ulrich Feige, Janet C. Cheetham
  • Thrombopoietic compounds
    Patent number: 8748571
    Abstract: The invention relates to the field of compounds, especially peptides or polypeptides, that have thrombopoietic activity. The peptides and polypeptides of the invention may be used to increase platelets or platelet precursors (e.g., megakaryocytes) in a mammal.
    Type: Grant
    Filed: October 20, 2011
    Date of Patent: June 10, 2014
    Assignee: Amgen Inc.
    Inventors: Chuan-Fa Liu, Ulrich Feige, Janet C. Cheetham
  • Thrombopoietic compounds
    Patent number: 8618044
    Abstract: The invention relates to the field of compounds, especially peptides or polypeptides, that have thrombopoietic activity. The peptides and polypeptides of the invention may be used to increase platelets or platelet precursors (e.g., megakaryocytes) in a mammal.
    Type: Grant
    Filed: April 27, 2012
    Date of Patent: December 31, 2013
    Assignee: Amgen Inc.
    Inventors: Chuan-Fa Liu, Ulrich Feige, Janet C. Cheetham
  • THROMBOPOIETIC COMPOUNDS
    Publication number: 20120208760
    Abstract: The invention relates to the field of compounds, especially peptides or polypeptides, that have thrombopoietic activity. The peptides and polypeptides of the invention may be used to increase platelets or platelet precursors (e.g., megakaryocytes) in a mammal.
    Type: Application
    Filed: April 27, 2012
    Publication date: August 16, 2012
    Applicant: AMGEN INC.
    Inventors: Chuan-Fa LIU, Ulrich FEIGE, Janet C. CHEETHAM
  • THROMBOPOIETIC COMPOUNDS
    Publication number: 20120034657
    Abstract: The invention relates to the field of compounds, especially peptides or polypeptides, that have thrombopoietic activity. The peptides and polypeptides of the invention may be used to increase platelets or platelet precursors (e.g., megakaryocytes) in a mammal.
    Type: Application
    Filed: October 20, 2011
    Publication date: February 9, 2012
    Applicant: AMGEN INC.
    Inventors: Chuan-Fa LIU, Ulrich FEIGE, Janet C. CHEETHAM
  • Thrombopoietic compounds
    Patent number: 8044174
    Abstract: The invention relates to the field of compounds, especially peptides or polypeptides, that have thrombopoietic activity. The peptides and polypeptides of the invention may be used to increase platelets or platelet precursors (e.g., megakaryocytes) in a mammal.
    Type: Grant
    Filed: September 2, 2004
    Date of Patent: October 25, 2011
    Assignee: Amgen Inc.
    Inventors: Chuan-Fa Liu, Ulrich Feige, Janet C. Cheetham
  • Thrombopoietic compounds
    Patent number: 7994117
    Abstract: The invention relates to the field of compounds, especially peptides or polypeptides, that have thrombopoietic activity. The peptides and polypeptides of the invention may be used to increase platelets or platelet precursors (e.g., megakaryocytes) in a mammal.
    Type: Grant
    Filed: March 13, 2009
    Date of Patent: August 9, 2011
    Assignee: Amgen Inc.
    Inventors: Chuan-Fa Liu, Ulrich Feige, Janet C. Cheetham
  • Thrombopoietic Compounds
    Publication number: 20090186822
    Abstract: The invention relates to the field of compounds, especially peptides or polypeptides, that have thrombopoietic activity. The peptides and polypeptides of the invention may be used to increase platelets or platelet precursors (e.g., megakaryocytes) in a mammal.
    Type: Application
    Filed: March 13, 2009
    Publication date: July 23, 2009
    Applicant: AMGEN INC.
    Inventors: Chuan-Fa Liu, Ulrich Feige, Janet C. Cheetham
  • Modified peptides as therapeutic agents
    Patent number: 7488590
    Abstract: Pharmacologically active compounds are prepared by (a) selecting at least one peptide that modulates the activity of AGP-3, (b) preparing a gene construct that comprises at least one said selected sequence, and (c) expressing the pharmacologically active compound in which an Fc domain is covalently linked to the selected peptide. The pharmacologic agent can be expressed in E. coli.
    Type: Grant
    Filed: August 18, 2003
    Date of Patent: February 10, 2009
    Assignee: Amgen Inc.
    Inventors: Ulrich Feige, Chuan-Fa Liu, Janet C. Cheetham, Thomas Charles Boone, Jean Marie Gudas
  • Thrombopoietic compounds
    Patent number: 6835809
    Abstract: The invention relates to the field of compounds, especially peptides or polypeptides, that have thrombopoietic activity. The peptides and polypeptides of the invention may be used to increase platelets or platelet precursors (e.g., megakaryocytes) in a mammal.
    Type: Grant
    Filed: October 22, 1999
    Date of Patent: December 28, 2004
    Assignee: Amgen Inc.
    Inventors: Chuan-Fa Liu, Ulrich Feige, Janet C. Cheetham
  • Modified peptides as therapeutic agents
    Publication number: 20040087778
    Abstract: The present invention concerns fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologically active peptides.
    Type: Application
    Filed: August 29, 2003
    Publication date: May 6, 2004
    Applicant: Amgen Inc.
    Inventors: Ulrich Feige, Chuan-Fa Liu, Janet C. Cheetham, Thomas Charles Boone
  • Modified peptides as therapeutic agents
    Publication number: 20040077022
    Abstract: The present invention concerns fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologically active peptides.
    Type: Application
    Filed: September 19, 2003
    Publication date: April 22, 2004
    Inventors: Ulrich Feige, Chun-Fa Liu, Janet C. Cheetham, Thomas Charles Boone, Jean Marie Gudas
  • Modified peptides as therapeutic agents
    Publication number: 20040071712
    Abstract: The present invention concerns fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologically active peptides.
    Type: Application
    Filed: August 18, 2003
    Publication date: April 15, 2004
    Applicant: Amgen Inc.
    Inventors: Ulrich Feige, Chuan-Fa Liu, Janet C. Cheetham, Thomas Charles Boone
  • Modified peptides as therapeutic agents
    Publication number: 20040057953
    Abstract: The present invention concerns fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologically active peptides.
    Type: Application
    Filed: August 29, 2003
    Publication date: March 25, 2004
    Applicant: Amgen Inc.
    Inventors: Ulrich Feige, Chuan-Fa Liu, Janet C. Cheetham, Thomas Charles Boone
  • Modified peptides as therapeutic agents
    Publication number: 20040053845
    Abstract: The present invention concerns fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologically active peptides.
    Type: Application
    Filed: July 31, 2003
    Publication date: March 18, 2004
    Applicant: Amgen Inc.
    Inventors: Ulrich Feige, Chuan-Fa Liu, Janet C. Cheetham, Thomas Charles Boone
  • Modified peptides as therapeutic agents
    Publication number: 20040044188
    Abstract: The present invention concerns fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologically active peptides.
    Type: Application
    Filed: June 27, 2003
    Publication date: March 4, 2004
    Applicant: Amgen Inc.
    Inventors: Ulrich Feige, Chuan-Fa Liu, Janet C. Cheetham, Thomas Charles Boone